STOCK TITAN

Insulet Corporation (PODD) Financials

PODD NASDAQ
Trailing 12 months to September 30, 2026
Revenue $3.2B +26.5% YoY
Net Income $428.8M +74.2% YoY
EPS (Diluted) $6.13 +78.2% YoY
Free Cash Flow $260.0M -38.6% YoY
Market Cap $9.7B as of Nov 18, 2026
Price / Sales 3.0x on $3.2B revenue, trailing 12 months to September 30, 2026
Price / Earnings 22.6x on $428.8M net income, trailing 12 months to September 30, 2026
Price / Book 6.1x on $1.6B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PODD SEC filings page.

Insulet Corporation (PODD) reported $3.2B in revenue over the twelve months to Sep 30, 2026, up 26.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PODD FY2025

Insulet’s expansion is producing more operating cash and using less debt, but 2025’s net income fell because the tax line reversed.

FY2025 operating cash flow reached $569M against net income of $247M, a 230.4% cash-conversion ratio showing that cash generation materially exceeded reported earnings. Yet operating margin rose 2.6 percentage points while net margin fell 11.1 percentage points, so the earnings decline was not an operating-margin story.

Debt-to-equity fell from 1.1x in FY2024 to 0.6x in FY2025, a meaningful shift toward equity financing as the asset base expanded. That makes the balance sheet less dependent on debt even though current liabilities rose, suggesting more near-term obligations within an otherwise de-levered structure.

The combination of 71.6% gross margin and 17.5% operating margin shows expansion is reaching operating profit, not stopping at product-level economics. Capital expenditures rose 53.4% while free-cash-flow margin slipped 0.8 percentage points, so stronger cash generation still requires substantial reinvestment.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 74 / 100
Financial Health Score 74/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Insulet Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
71

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Insulet Corporation scores 71/100 on it among other operating companies.

Growth
86

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Insulet Corporation scores 86/100 on it among other operating companies.

Leverage
70

Insulet Corporation's net debt of $214.7M, being $930.8M of long-term debt less $716.1M of cash, came to 0.38 times its EBITDA in fiscal year 2025. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Insulet Corporation scores 70/100 among other operating companies measured the same way.

Liquidity
76

Insulet Corporation held $2.81 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 2.81. Liquidity ranks operating companies on that ratio, and Insulet Corporation scores 76/100 among other operating companies.

Cash Flow
71

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Insulet Corporation scores 71/100 on it among other operating companies.

Returns
72

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Insulet Corporation scores 72/100 on it among other operating companies.

Altman Z-Score Safe
5.41

Insulet Corporation scores 5.41, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $9.7B against total liabilities of $1.7B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Insulet Corporation passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
2.30x

For every $1 of reported earnings, Insulet Corporation generates $2.30 in operating cash flow ($569.3M OCF vs $247.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
7.98x

Insulet Corporation earns $7.98 in operating income for every $1 of interest expense ($473.8M vs $59.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$842.0M
YoY+19.2%
QoQ+5.0%
5Y CAGR+25.0%
10Y CAGR+24.4%

Insulet Corporation generated $842.0M in revenue in Q3 2026. This represents an increase of 19.2% from the same quarter a year earlier. Against the prior quarter it is up 5.0%.

EBITDA
$218.0M
YoY+56.0%
QoQ+39.4%
5Y CAGR+35.2%

Insulet Corporation's EBITDA was $218.0M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 56.0% from the same quarter a year earlier. Against the prior quarter it is up 39.4%.

Net Income
$141.1M
YoY+61.1%
QoQ+48.5%
5Y CAGR+62.1%
10Y CAGRn/m

Insulet Corporation reported $141.1M in net income in Q3 2026. This represents an increase of 61.1% from the same quarter a year earlier. Against the prior quarter it is up 48.5%.

EPS (Diluted)
$2.03
YoY+63.7%
QoQ+48.2%
5Y CAGR+62.3%
10Y CAGRn/m

Insulet Corporation earned $2.03 per diluted share (EPS) in Q3 2026. This represents an increase of 63.7% from the same quarter a year earlier. Against the prior quarter it is up 48.2%.

Cash & Balance Sheet

Free Cash Flow
$66.4M
YoY-33.7%
QoQ+18.8%
5Y CAGRn/m
10Y CAGRn/m

Insulet Corporation generated $66.4M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 33.7% from the same quarter a year earlier. Against the prior quarter it is up 18.8%.

Cash & Debt
$584.4M
YoY-22.8%
QoQ+9.3%
5Y CAGR-7.4%
10Y CAGR+10.5%

Insulet Corporation held $584.4M in cash against $943.0M in long-term debt as of Q3 2026.

Shares Outstanding
69M
YoY-1.4%
QoQ0.0%
5Y CAGR+0.1%
10Y CAGR+1.9%

Insulet Corporation had 69M shares outstanding in Q3 2026. This represents a decrease of 1.4% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
75.1%
YoY+2.9pp
QoQ+4.9pp
5Y change+6.6pp
10Y change+16.4pp

Insulet Corporation's gross margin was 75.1% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.9 percentage points.

Operating Margin
22.5%
YoY+5.9pp
QoQ+6.4pp
5Y change+10.3pp

Insulet Corporation's operating margin was 22.5% in Q3 2026, reflecting core business profitability. This is up 5.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.4 percentage points.

Net Margin
16.8%
YoY+4.4pp
QoQ+4.9pp
5Y change+12.2pp
10Y change+20.0pp

Insulet Corporation's net profit margin was 16.8% in Q3 2026, showing the share of revenue converted to profit. This is up 4.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.9 percentage points.

Return on Equity
8.9%
YoY+2.6pp
QoQ+2.3pp
5Y change+6.4pp
10Y change+13.7pp

Insulet Corporation's quarterly ROE was 8.9% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.3 percentage points.

Capital Allocation

R&D Spending
$91.6M
YoY+18.7%
QoQ+4.0%
5Y CAGR+19.6%

Insulet Corporation invested $91.6M in research and development in Q3 2026. This represents an increase of 18.7% from the same quarter a year earlier. Against the prior quarter it is up 4.0%.

Share Buybacks
$0
YoY-100.0%
QoQn/m

Insulet Corporation repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Capital Expenditures
$57.1M
YoY+123.0%
QoQ+75.7%
5Y CAGR+15.9%
10Y CAGR+15.7%

Insulet Corporation invested $57.1M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 123.0% from the same quarter a year earlier. Against the prior quarter it is up 75.7%.

PODD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PODD quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$842.0M+19.2%$801.7M+23.5%$761.7M+33.9%$783.7M+31.2%$706.3M+29.9%$649.1M+32.9%$569.0M+28.8%$597.5M+17.2%
Cost of Revenue$209.9M+7.0%$239.1M+21.4%$232.7M+45.5%$215.2M+29.2%$196.2M+17.6%$196.9M+24.9%$159.9M+18.5%$166.6M+12.1%
Gross Profit$632.1M+23.9%$562.6M+24.4%$529.1M+29.4%$568.6M+32.0%$510.1M+35.3%$452.2M+36.7%$409.0M+33.3%$430.9M+19.3%
R&D Expenses$91.6M+18.7%$88.1M+20.0%$89.7M+50.5%$90.9M+50.0%$77.2M+40.6%$73.4M+36.2%$59.6M+18.7%$60.6M+44.3%
SG&A Expenses$350.7M+11.3%$344.8M+33.8%$317.2M+21.7%$331.4M+27.0%$315.2M+34.6%$257.7M+15.8%$260.7M+30.5%$260.9M+22.7%
Operating Income$189.8M+61.3%$129.7M+7.1%$122.1M+37.5%$146.2M+33.6%$117.7M+33.6%$121.1M+122.2%$88.8M+56.1%$109.4M+2.7%
EBITDA$218.0M+56.0%$156.4M+9.1%$148.3M+34.2%$170.6M+30.3%$139.7M+27.7%$143.4M+94.6%$110.5M+46.0%$130.9M+4.5%
Interest Expense$16.2M+3.8%$13.5M-31.1%$14.7M+59.8%$15.0M+74.4%$15.6M+25.8%$19.6M+78.2%$9.2M-14.0%$8.6M+28.4%
Income Tax$36.1M+2.6%$23.7M+301.7%$21.9M+72.4%$38.6M+264.2%$35.2M+551.9%$5.9Mn/m$12.7M+273.5%$10.6M+135.6%
Net Income$141.1M+61.1%$95.0M+322.2%$91.1M+157.3%$101.6M+0.9%$87.6M+13.0%$22.5M-88.1%$35.4M-31.3%$100.7M-2.5%
EPS (Basic)$2.03+63.7%$1.37+328.1%$1.30+160.0%$1.440.0%$1.24+11.7%$0.32-88.1%$0.50-32.4%$1.44-2.7%
EPS (Diluted)$2.03+63.7%$1.37+328.1%$1.30+160.0%$1.43+3.6%$1.24+14.8%$0.32-87.6%$0.50-31.5%$1.38-6.1%
Diluted Shares (Avg)69M-1.7%69M-1.8%70M-5.3%N/A71M-4.4%71M-4.3%74M+0.5%N/A

PODD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PODD quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$3.4B+12.7%$3.2B-8.8%$3.0B-15.1%$3.2B+3.3%$3.0B+0.1%$3.5B+20.4%$3.5B+34.0%$3.1B+19.3%
Current Assets$2.0B+9.8%$1.8B-18.9%$1.7B-26.6%$1.9B+1.2%$1.9B-0.1%$2.3B+30.4%$2.3B+43.9%$1.9B+19.5%
Cash & Equivalents$584.4M-22.8%$534.9M-52.3%$480.4M-62.6%$716.1M-24.9%$757.4M-16.1%$1.1B+36.6%$1.3B+70.8%$953.4M+35.4%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0$0n/m$0n/m$0n/m
Inventory$552.1M+23.7%$484.8M+8.5%$462.5M+4.9%$452.6M+5.2%$446.3M+0.3%$446.9M+3.7%$440.8M+2.4%$430.4M+6.9%
Accounts Receivable$689.0M$588.7M$544.7M$516.9MN/AN/AN/AN/A
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0$0n/m$0n/m$0n/m
Goodwill$51.6M0.0%$51.6M-0.2%$51.6M+0.2%$51.6M+0.2%$51.6M-0.2%$51.7M0.0%$51.5M-0.4%$51.5M-0.4%
Total Liabilities$1.8B+11.6%$1.7B-13.1%$1.7B-23.0%$1.7B-10.7%$1.6B-13.8%$2.0B+6.5%$2.2B+19.3%$1.9B+1.1%
Current Liabilities$814.4M+25.7%$744.2M-26.3%$687.5M+32.1%$680.1M+28.7%$647.7M+28.0%$1.0B+107.8%$520.4M+20.4%$528.4M+17.1%
Non-Current Liabilities$1.0B+2.4%$998.7M+0.3%$997.1M-40.2%$995.1M-26.2%$997.4M-28.8%$996.2M-28.7%$1.7B+18.9%$1.3B-4.0%
Long-Term Debt$943.0M+0.9%$929.5M-1.0%$929.5M-42.3%$930.8M-28.2%$934.9M-31.1%$939.0M-31.0%$1.6B+18.3%$1.3B-5.1%
Total Equity$1.6B+14.1%$1.4B-2.8%$1.3B-2.1%$1.5B+25.1%$1.4B+23.8%$1.5B+46.5%$1.3B+68.3%$1.2B+65.4%
Retained Earnings$614.5M+230.7%$473.5M+382.2%$378.5M+400.0%$287.4M+613.2%$185.8Mn/m$98.2Mn/m$75.7Mn/m$40.3Mn/m

PODD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PODD quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$123.5M-1.8%$88.4M-55.0%$113.8M+78.4%$183.3M+24.3%$125.7M+16.1%$196.5M+126.4%$63.8M-27.2%$147.5M+226.3%
Depreciation & Amortization$28.2M+28.2%$26.7M+19.7%$26.2M+20.7%$24.4M+13.5%$22.0M+3.3%$22.3M+16.1%$21.7M+15.4%$21.5M+14.4%
Stock-Based Compensation$20.5M+22.8%$19.7M+162.7%$21.3M+17.0%N/A$16.7M-8.2%$7.5M-55.9%$18.2M+28.2%N/A
Capital Expenditures$57.1M+123.0%$32.5M+74.7%$24.3M+97.6%$135.1M+152.1%$25.6M-4.1%$18.6M-17.3%$12.3M-44.3%$53.6M+82.9%
Free Cash Flow$66.4M-33.7%$55.9M-68.6%$89.5M+73.8%$48.2M-48.7%$100.1M+22.7%$177.9M+176.7%$51.5M-21.4%$93.9M+490.6%
Investing Cash Flow-$66.9Mn/m-$37.4Mn/m-$27.7Mn/m-$152.8Mn/m-$31.0Mn/m-$23.3Mn/m-$15.6Mn/m-$68.0Mn/m
Financing Cash Flow-$6.0Mn/m$4.0Mn/m-$319.9M-215.2%-$72.5Mn/m-$457.0Mn/m-$343.5M-4003.4%$277.7Mn/m-$20.8M-1045.5%
Share Buybacks$0-100.0%$0-100.0%$300.0Mn/m$0n/m$29.5Mn/m$30.1M$0$0

Not reported in any period shown, so not listed: Dividends Paid.

PODD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PODD quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin75.1%+2.9pp70.2%+0.5pp69.5%-2.4pp72.5%+0.4pp72.2%+2.9pp69.7%+1.9pp71.9%+2.4pp72.1%+1.3pp
Operating Margin22.5%+5.9pp16.2%-2.5pp16.0%+0.4pp18.7%+0.3pp16.7%+0.5pp18.7%+7.5pp15.6%+2.7pp18.3%-2.6pp
Net Margin16.8%+4.4pp11.8%+8.4pp12.0%+5.7pp13.0%-3.9pp12.4%-1.8pp3.5%-35.1pp6.2%-5.4pp16.9%-3.4pp
Return on Equity8.9%+2.6pp6.7%+5.1pp7.0%+4.3pp6.7%-1.6pp6.3%-0.6pp1.5%-17.4pp2.7%-3.9pp8.3%-5.8pp
Return on Assets4.1%+1.2pp3.0%+2.4pp3.0%+2.0pp3.2%-0.1pp2.9%+0.3pp0.7%-5.9pp1.0%-0.9pp3.3%-0.7pp
Current Ratio2.51-0.4x2.48+0.2x2.49-2.0x2.81-0.8x2.87-0.8x2.26-1.3x4.47+0.7x3.58+0.1x
Debt-to-Equity0.60-0.1x0.650.0x0.71-0.5x0.61-0.5x0.68-0.5x0.64-0.7x1.21-0.5x1.07-0.8x
Liabilities-to-Equity1.160.0x1.23-0.1x1.29-0.4x1.11-0.4x1.19-0.5x1.37-0.5x1.64-0.7x1.55-1.0x
Asset Turnover0.250.0x0.25+0.1x0.26+0.1x0.25+0.1x0.23+0.1x0.190.0x0.160.0x0.190.0x
FCF Margin7.9%-6.3pp7.0%-20.4pp11.8%+2.7pp6.2%-9.6pp14.2%-0.8pp27.4%+14.3pp9.0%-5.8pp15.7%+12.6pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Insulet Corporation PODD FY2025 $2.7B $247.1M 9.1% $9.7B 74/100
Smith & Nephew plc SNN FY2025 $6.2B $625.0M 10.1% $12.7B 62/100
Penumbra, Inc. PEN FY2025 $1.4B $177.7M 12.7% $12.6B 69/100
Glaukos Corporation GKOS FY2025 $507.4M -$187.7M -37.0% $13.8B 51/100
Zimmer Biomet Holdings, Inc. ZBH FY2025 $8.2B $705.1M 8.6% $19.6B 60/100
STERIS plc STE FY2026 $5.9B $782.3M 13.2% $25.2B 68/100

Frequently Asked Questions

Insulet Corporation (PODD) reported $2.7B in total revenue for fiscal year 2025. This represents a 30.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Insulet Corporation (PODD) revenue grew by 30.7% year-over-year, from $2.1B to $2.7B in fiscal year 2025.

Yes, Insulet Corporation (PODD) reported a net income of $428.8M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $247.1M, with a net profit margin of 9.1%.

Insulet Corporation (PODD) reported diluted earnings per share of $3.48 for fiscal year 2025. This represents a -39.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Insulet Corporation (PODD) had EBITDA of $564.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Insulet Corporation (PODD) had $716.1M in cash and equivalents against $930.8M in long-term debt.

Insulet Corporation (PODD) had a gross margin of 71.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Insulet Corporation (PODD) had an operating margin of 17.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Insulet Corporation (PODD) had a net profit margin of 9.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Insulet Corporation (PODD) has a return on equity of 16.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Insulet Corporation (PODD) generated $377.7M in free cash flow during fiscal year 2025. This represents a 23.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Insulet Corporation (PODD) generated $569.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Insulet Corporation (PODD) had $3.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Insulet Corporation (PODD) invested $191.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Insulet Corporation (PODD) invested $301.1M in research and development during fiscal year 2025.

Yes, Insulet Corporation (PODD) spent $59.6M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Insulet Corporation (PODD) had 70M shares outstanding as of fiscal year 2025.

Insulet Corporation (PODD) had a current ratio of 2.81 as of fiscal year 2025, which is generally considered healthy.

Insulet Corporation (PODD) had a debt-to-equity ratio of 0.61 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Insulet Corporation (PODD) had a liabilities-to-equity ratio of 1.11 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Insulet Corporation (PODD) had a return on assets of 7.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Insulet Corporation (PODD) trades at 22.6x earnings, its market capitalization divided by $428.8M net income, trailing 12 months to September 30, 2026. The market capitalization is $9.7B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Insulet Corporation (PODD) trades at 3.0x sales, its market capitalization divided by $3.2B revenue, trailing 12 months to September 30, 2026. The market capitalization is $9.7B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Insulet Corporation (PODD) has an Altman Z-Score of 5.41, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Insulet Corporation (PODD) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Insulet Corporation (PODD) has an earnings quality ratio of 2.30x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Insulet Corporation (PODD) has an interest coverage ratio of 7.98x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Insulet Corporation (PODD) scores 74 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top